Radiation options for early prostate cancer-related erections
Part of Cancer, Kidney & urinary clinical trials.
This study compares two radiation treatments—seed brachytherapy and stereotactic body radiotherapy—to see which better preserves erections in men with early- to mid-risk prostate cancer. It’s designed to help patients understand how different curative radiation choices can affect sexual function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have prostate cancer confirmed by biopsy (prostate adenocarcinoma).
- Your cancer is considered low risk (T1 to T2a, PSA under 10, Gleason 6) or intermediate risk without a specific higher-grade pattern (no Gleason 7 with pattern 4+3).
- Your doctors decided you should receive a curative treatment using brachytherapy (seed radiation), after a team review.
- You are not currently receiving hormone-blocking treatment (androgen deprivation therapy).
- You can safely receive seed radiation and MRI: no iodine 125 brachytherapy issues (like prostate size over 50 cc) and you can tolerate MRI (not severe claustrophobia, and no pacemaker).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new radiation technique to better protect erectile function during prostate cancer treatment. It uses advanced imaging to precisely target the tumor while reducing harm to nearby structures.
This trial compares two types of radiation therapy (SBRT and LDR brachytherapy) for men with low-risk or favorable intermediate-risk prostate cancer. The goal is to see which treatment causes fewer side effects.
This study tests a focused (“salvage”) brachytherapy—radiation placed directly near the prostate—to treat prostate cancer that has returned after earlier radiation. It may help control the tumor while limiting radiation exposure to surrounding tissues, based on how well people fit the study’s safety and cancer details.
This early-phase study tests a prostate radiation approach given in two treatments, planned using MRI. It’s designed for men with lower-to-intermediate risk prostate cancer and aims to see if this method is safe and works well.
This study compares two ways of giving radiation to the prostate, including a “boost” using a special internal radiation treatment. It’s meant to see which radiation schedule works better and is safer for certain prostate cancer patients.
This study looks at whether re-treating prostate cancer with radiation (after it came back) can be done safely and how side effects affect people. It also checks whether this approach is practical to carry out, especially for urinary side effects and comfort during the process.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.